All In Biotech

Drug Trial Radar · NCT06285643

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults With Moderate Stage Parkinson's Disease

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

59

Actual

Start

Jun 11, 2024

Primary completion

Aug 31, 2028

Study completion Aug 31, 2028

Sponsor

Lead sponsor
AskBio IncIndustry
Sponsor type
Industry
Collaborators
Bayer
First posted
Feb 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

Conditions

  • Parkinson Disease

Interventions

  • AAV2-GDNF gene therapyDrug

    Bilateral image-guided infusion of AAV2-GDNF into putamen, single dose

  • control surgeryProcedure

    Bilateral partial burr/twist holes without dural penetration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to Month 18 on PD Motor DiaryTime frame: 18 months

Locations

46 sites in 4 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Phoenix, Arizona

  • UCI Alpha Clinic (Neurology)

    Irvine, California

  • Loma Linda University (Neurology)

    Loma Linda, California

  • Loma Linda University (Surgical)

    Loma Linda, California

  • University of California San Francisco (Neurology)

    San Francisco, California

  • University of San Francisco (Surgical)

    San Francisco, California

  • CenExel Rocky Mountain Clinical Research (Neurology)

    Englewood, Colorado

  • Georgetown University (Neurology)

    Washington D.C., District of Columbia

  • Parkinson's Disease and Movement Disorders Center of Boca Raton (Neurology)

    Boca Raton, Florida

  • University of Florida

    Gainesville, Florida

  • University of Miami

    Miami, Florida

  • Orlando Health Neuroscience Institute

    Orlando, Florida

  • Parkinson's Disease Treatment Center of Southwest Florida (Neurology)

    Port Charlotte, Florida

  • Emory University (Surgical)

    Atlanta, Georgia

  • Rush University Medical Center (Neurology)

    Chicago, Illinois

  • University of Kansas Medical Center (Neurology)

    Kansas City, Kansas

  • Massachusetts General Hospital (Neurology)

    Boston, Massachusetts

  • Massachusetts General Hospital (Surgical)

    Boston, Massachusetts

  • Michigan State University (Neurology)

    East Lansing, Michigan

  • Quest Research Institute (Neurology)

    Farmington Hills, Michigan

  • Cleveland Clinic Lou Ruvo (Neurology)

    Las Vegas, Nevada

  • Columbia University

    New York, New York

  • University of North Carolina (Neurology)

    Chapel Hill, North Carolina

  • Duke Neurosurgery (Surgical)

    Durham, North Carolina

  • Duke University (Neurology)

    Durham, North Carolina

  • Ohio State University (Surgical)

    Columbus, Ohio

  • University of Pennsylvania (Neurology)

    Philadelphia, Pennsylvania

  • Vanderbilt University (Neurology)

    Nashville, Tennessee

  • Texas Movement Disorder Specialists

    Georgetown, Texas

  • Houston Methodist (Neurology)

    Houston, Texas

  • Houston Methodist (Surgical)

    Houston, Texas

  • University of Utah

    Salt Lake City, Utah

  • EvergreenHealth Research Department (Neurology)

    Kirkland, Washington

  • University of Wisconsin (Neurology)

    Madison, Wisconsin

  • Charité - Universitätsmedizin Berlin (Surgical)

    Berlin, Germany

  • Philipps-Universität Marburg (Neurology)

    Marburg, Germany

  • Universitätsklinikum Tübingen (Neurology)

    Tübingen, Germany

  • Universitätsklinikum Tübingen (Surgical)

    Tübingen, Germany

  • Universitätsklinikum Würzburg (Neurology)

    Würzburg, Germany

  • Copernicus Podmiot Leczniczy, Szpital św. Wojciecha (Neurology)

    Gdansk, Poland

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.